Avoiding Exploitation in Phase I Clinical Trials: More than (Un)Just Compensation

scientific article published on 27 March 2018

Avoiding Exploitation in Phase I Clinical Trials: More than (Un)Just Compensation is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1177/1073110518766008
P932PMC publication ID6047746
P698PubMed publication ID30026654

P2093author name stringCarl Elliott
Matt Lamkin
P2860cites workNoradrenergic and serotonergic function in posttraumatic stress disorderQ73665569
Guinea-pigging: healthy human subjects for drug safety trials are in demand. But is it a living?Q80674433
Exploiting a research underclass in phase 1 clinical trialsQ81351452
Human research subjects as human research workersQ95449947
Quantifying the risks of non-oncology phase I research in healthy volunteers: meta-analysis of phase I studiesQ28647898
Money, coercion, and undue inducement: attitudes about payments to research participants.Q30409916
The calm after the cytokine storm: lessons from the TGN1412 trialQ30481519
What makes clinical research ethical?Q33924008
Guinea pigs on the payroll: the ethics of paying research subjectsQ34412409
Paying research subjects: an analysis of current policiesQ34549837
Voluntariness of consent for research: an empirical and conceptual reviewQ34844724
Feeding and Bleeding: The Institutional Banalization of Risk to Healthy Volunteers in Phase I Pharmaceutical Clinical TrialsQ35518249
Ending concerns about undue inducementQ35777913
Comprehension and informed consent: assessing the effect of a short consent formQ36761326
Misconceptions about coercion and undue influence: reflections on the views of IRB membersQ37090609
'I'm still a hustler': entrepreneurial responses to precarity by participants in phase I clinical trialsQ37161318
Payments to normal healthy volunteers in phase 1 trials: avoiding undue influence while distributing fairly the burdens of research participationQ37192426
Research-related injury compensation policies of U.S. research institutionsQ37709422
Improving the informed consent process for research subjects with low literacy: a systematic reviewQ38025315
The institutional review board and beyond: future challenges to the ethics of human experimentationQ40377323
Risk and Emotion Among Healthy Volunteers in Clinical TrialsQ41592194
Johns Hopkins admits fault in fatal experiment.Q44087564
The concept of voluntary consentQ48120516
Why healthy subjects volunteer for phase I studies and how they perceive their participation?Q48382683
Justice for injured research subjectsQ48420730
Recovering from research: a no-fault proposal to compensate injured research participantsQ48456045
The human subjects trade: ethical and legal issues surrounding recruitment incentivesQ48571469
To screen new drugs for safety, Lilly pays homeless alcoholics: it's 'quick cash' to habitues of Indianapolis shelters; it vanishes quickly, too.Q48779234
Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics.Q51536942
New York seeks to tighten rules on medical research.Q51562024
Research participation and financial inducements.Q52884806
The Death of Jesse Gelsinger: New Evidence of the Influence of Money and Prestige in Human ResearchQ53065419
Voluntariness of consent to research: a conceptual model.Q53115258
Undue Inducement: Nonsense on Stilts?Q57988588
Challenging assumptions about minority participation in US clinical researchQ66829165
P433issue1
P921main subjectphase I clinical trialQ5452194
P304page(s)52-63
P577publication date2018-03-27
P1433published inJournal of Law, Medicine, and EthicsQ15760852
P1476titleAvoiding Exploitation in Phase I Clinical Trials: More than (Un)Just Compensation
P478volume46

Reverse relations

Q90446884"Money Helps": People who inject drugs and their perceptions of financial compensation and its ethical implicationscites workP2860

Search more.